GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
ARDEA BIOSCIENCES (RDEA) [hlAlert]

Rating:
Outperform
RDEA

ARDEA BIOSCIENCES (RDEA) rated Outperform by Boenning & Scattergood

Posted on: Tuesday,  May 31, 2011  10:25 AM ET by Boenning & Scattergood

ARDEA BIOSCIENCES (NASDAQ:
RDEA) rated Outperform by Boenning & Scattergood.

Ardea Biosciences, Inc. is a biotechnology company focused on the discovery and development of small-molecule therapeutics for the treatment of human immunodeficiency virus (HIV), cancer and inflammatory diseases, including gout. The Company's portfolio of product candidates include RDEA806 and 2nd generation non-nucleoside reverse transcriptase inhibitor (NNRTI) for HIV indication; RDEA594 for gout; RDEA119 for cancer; RDEA119 for inflammation, and mitogen-activated ERK kinase (MEK) inhibitor for cancer/inflammation.

Our equity research team concentrates on companies that aren’t widely covered in sectors such as water distribution/equipment/technology, financial services, business services, aerospace & defense technology, medical technology and retail.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/31/2011 10:25 AM Buy
None
24.75
as of 12/30/2011
1 Week down  -3.99 %
1 Month down  -10.01 %
3 Months up  7.61 %
1 YTD down  -32.08 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy